Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ANZCTR |
Last refreshed on:
|
13 January 2020 |
Main ID: |
ACTRN12614001016628 |
Date of registration:
|
22/09/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
The Effects Of Intraarticular Platelet Rich Plasma versus Steroid Injection In Meniscal Injuries- A Randomized Controlled Trial
|
Scientific title:
|
A randomised controlled trial to evaluate the effect of intraarticular platelet rich plasma injection versus intraarticular triamcinolone acetonide injection on pain relief and functional outcomes in adult males with meniscal injuries |
Date of first enrolment:
|
07/07/2014 |
Target sample size:
|
30 |
Recruitment status: |
Recruiting |
URL:
|
https://anzctr.org.au/ACTRN12614001016628.aspx |
Study type:
|
Interventional |
Study design:
|
Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
Pakistan
| | | | | | | |
Contacts
|
Name:
|
Dr Sarah Razaq
|
Address:
|
Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan
Pakistan |
Telephone:
|
+923336123022 |
Email:
|
docsr@hotmail.com |
Affiliation:
|
|
|
Name:
|
Dr Sarah Razaq
|
Address:
|
Major Sarah Razaq, classified rehab specialist, Rehab department, Combined Military Hospital, Panoaqil cantt (65120), distt Sukkur, Sindh, Pakistan
Pakistan |
Telephone:
|
+923336123022 |
Email:
|
docsr@hotmail.com |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Age more than 18 yrs,
knee pain lasting more than 3 months,
History of twisting injury to knee,
Clinical and MRI evidence of meniscal injuries
Exclusion criteria: Other Intraarticular knee injections in last 3 months
Age minimum:
18 Years
Age maximum:
40 Years
Gender:
Males
|
Health Condition(s) or Problem(s) studied
|
Meniscal injuries; Meniscal injuries
|
Musculoskeletal - Other muscular and skeletal disorders
|
Intervention(s)
|
Two intraarticular knee injection of 3 ml of platelet rich plasma will be given 2 weeks apart in total. Platelet rich plasma will be obtained from patient's own blood. 30 ml of venous blood will be taken from the patient, which will yield 3 ml of Platelet rich plasma.
|
Primary Outcome(s)
|
Knee pain will be assessed using Visual analogue scale (VAS)[At baseline, 4 and 12 weeks ater intervention]
|
Secondary Outcome(s)
|
Adverse events including: 1. Increase in pain
2. Swelling
3. Difficulty in walking[0,4 12 weeks]
|
Knee injury and osteoarthritis outcome score (KOOS) will be used to assess the knee function, symptomatic improvement, pain, stiffness in knee, [At baseline, 4 and 12 weeks ater intervention]
|
patient satisfaction in YES/NO[0,4, 12 weeks]
|
Source(s) of Monetary Support
|
Combined Military Hospital, Panoaqil
|
Ethics review
|
Status: Approved
Approval date:
Contact:
CMH Panoaqil ethics committee
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|